113 related articles for article (PubMed ID: 21986841)
1. Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I.
Bujnicki T; Wilczek C; Schomburg C; Feldmann F; Schlenke P; Müller-Tidow C; Schmidt TJ; Klempnauer KH
Leukemia; 2012 Apr; 26(4):615-22. PubMed ID: 21986841
[TBL] [Abstract][Full Text] [Related]
2. Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships.
Schomburg C; Schuehly W; Da Costa FB; Klempnauer KH; Schmidt TJ
Eur J Med Chem; 2013 May; 63():313-20. PubMed ID: 23501116
[TBL] [Abstract][Full Text] [Related]
3. QSAR of Natural Sesquiterpene Lactones as Inhibitors of Myb-dependent Gene Expression.
Castellano G; Redondo L; Torrens F
Curr Top Med Chem; 2018 Feb; 17(30):3256-3268. PubMed ID: 29231144
[TBL] [Abstract][Full Text] [Related]
4. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of c-myb in the chicken pre B-cell line DT40.
Appl H; Klempnauer KH
Oncogene; 2002 May; 21(19):3076-81. PubMed ID: 12082539
[TBL] [Abstract][Full Text] [Related]
6. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
Chen J; Kremer CS; Bender TP
Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
[TBL] [Abstract][Full Text] [Related]
7. Three genes with different functions in transformation are regulated by c-Myb in myeloid cells.
Wolff L; Schmidt M; Koller R; Haviernik P; Watson R; Bies J; Maciag K
Blood Cells Mol Dis; 2001; 27(2):483-8. PubMed ID: 11259171
[TBL] [Abstract][Full Text] [Related]
8. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
10. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
[TBL] [Abstract][Full Text] [Related]
11. Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562.
Kasono K; Heike Y; Xiang J; Piché A; Kim HG; Kim M; Hagiwara M; Nawrath M; Moelling K; Curiel DT
Cancer Gene Ther; 2000 Jan; 7(1):151-9. PubMed ID: 10678368
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
13. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
14. Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.
Uttarkar S; Piontek T; Dukare S; Schomburg C; Schlenke P; Berdel WE; Müller-Tidow C; Schmidt TJ; Klempnauer KH
Mol Cancer Ther; 2016 Dec; 15(12):2905-2915. PubMed ID: 27707899
[TBL] [Abstract][Full Text] [Related]
15. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
16. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
18. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
[TBL] [Abstract][Full Text] [Related]
19. The myb oncogene.
Lipsick JS; Baluda MA
Gene Amplif Anal; 1986; 4():73-98. PubMed ID: 3333362
[TBL] [Abstract][Full Text] [Related]
20. The chicken A-myb protein is a transcriptional activator.
Foos G; Grimm S; Klempnauer KH
Oncogene; 1994 Sep; 9(9):2481-8. PubMed ID: 8058311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]